Growth Metrics

Merck (MRK) Receivables - Other (2016 - 2023)

Merck has reported Receivables - Other over the past 12 years, most recently at $473.0 million for Q1 2023.

  • Quarterly Receivables - Other fell 34.21% to $473.0 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $473.0 million through Mar 2023, down 34.21% year-over-year, with the annual reading at $511.0 million for FY2022, 46.99% down from the prior year.
  • Receivables - Other was $473.0 million for Q1 2023 at Merck, down from $511.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $1.6 billion in Q2 2021 and troughed at $473.0 million in Q1 2023.
  • The 3-year median for Receivables - Other is $684.0 million (2022), against an average of $860.4 million.
  • Year-over-year, Receivables - Other tumbled 59.5% in 2022 and then tumbled 34.21% in 2023.
  • A 3-year view of Receivables - Other shows it stood at $964.0 million in 2021, then plummeted by 46.99% to $511.0 million in 2022, then dropped by 7.44% to $473.0 million in 2023.
  • Per Business Quant, the three most recent readings for MRK's Receivables - Other are $473.0 million (Q1 2023), $511.0 million (Q4 2022), and $567.0 million (Q3 2022).